ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BLUE bluebird bio Inc

0.95845
-0.02515 (-2.56%)
Last Updated: 10:38:48
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,383,160
Bid Price 0.9569
Ask Price 0.9599
News -
Day High 0.99

Low
0.851

52 Week Range

High
5.53

Day Low 0.93
Company Name Stock Ticker Symbol Market Type
bluebird bio Inc BLUE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02515 -2.56% 0.95845 10:38:48
Open Price Low Price High Price Close Price Prev Close
0.9873 0.93 0.99 0.9836
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,874 1,383,160 $ 0.9567634 $ 1,323,357 - 0.851 - 5.53
Last Trade Time Type Quantity Stock Price Currency
10:39:24 1 $ 0.9584 USD

bluebird bio (BLUE) Options Flow Summary

Overall Flow

Bearish

Net Premium

-34k

Calls / Puts

0.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

bluebird bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
106.06M 109.34M - 3.6M -266.58M -2.44 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

bluebird bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BLUE Message Board. Create One! See More Posts on BLUE Message Board See More Message Board Posts

Historical BLUE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.081.080.931.013,788,864-0.12155-11.25%
1 Month0.921.230.8510.98376236,744,0410.038454.18%
3 Months1.681.740.8511.207,330,392-0.72155-42.95%
6 Months3.755.530.8511.6110,441,952-2.79-74.44%
1 Year3.7355.530.8512.117,127,458-2.78-74.34%
3 Years31.7335.58830.8514.694,971,600-30.77-96.98%
5 Years123.94143.980.85112.033,431,299-122.98-99.23%

bluebird bio Description

bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.